AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014
Mar 21, 2014
30583_dirs_2014-03-21_f73ded4d-14c5-4efc-b795-289b69bb63c0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-03-19
Reporting Person: Slamon Dennis (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-19 | Common Stock | A | 4000 | — | Acquired | 4700 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-19 | Stock Option (right to buy) | $79.70 | A | 10000 | Acquired | 2024-03-18 | Common Stock (10000) | Direct |
Footnotes
F1: Restricted stock units granted on March 19, 2013. Price not applicable.
F2: Original option grant vests quarterly over three years.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19